🧬 Retatrutide Peptide — 10 mg

High‑Purity Triple‑Agonist Research Peptide for Metabolic & Receptor‑Signaling Studies (Canada)

Retatrutide is a high‑purity, research‑grade synthetic long‑chain peptide engineered as a triple‑agonist analog targeting GLP‑1 receptor (GLP‑1R), GIP receptor (GIPR), and glucagon receptor (GCGR) signaling pathways. It is widely referenced in laboratory research involving multi‑receptor metabolic signaling, energy‑regulation models, and advanced incretin‑pathway biology.

Supplied by BlueNexLabs, Retatrutide is available as a lyophilized research peptide in 10 mg, 20 mg, and 30 mg fill sizes, with COA‑verified purity, analytical consistency, and audit‑safe Research‑Use‑Only (RUO) labeling, supporting advanced experimental workflows in Canadian research environments.

🔬 Overview of Retatrutide in Research Settings

Retatrutide is designed to support simultaneous investigation of three hormonally linked receptor systems, making it a valuable model compound for exploring how balanced vs. biased receptor activation influences downstream metabolic signaling.

In controlled laboratory settings, Retatrutide is commonly referenced in studies examining:

• Multi‑agonist incretin‑pathway signaling

• Receptor cross‑talk between GLP‑1R, GIPR, and GCGR

• Energy‑regulation and metabolic‑stress adaptation models

• Receptor‑specific vs. integrated transcriptional responses

• Structure–function relationships in long‑chain peptide analogs

Its triple‑agonist architecture enables side‑by‑side comparison of single‑, dual‑, and multi‑receptor activation paradigms.

🧪 What Is Retatrutide?

Retatrutide is a synthetic triple‑agonist research peptide designed for laboratory studies involving concurrent activation of:

• GLP‑1R (glucagon‑like peptide‑1 receptor)

• GIPR (glucose‑dependent insulinotropic polypeptide receptor)

• GCGR (glucagon receptor)

This multi‑receptor engagement allows researchers to investigate coordinated incretin and glucagon pathway signaling within a single experimental system.

In research contexts, Retatrutide supports studies involving:

• Complex metabolic‑signaling integration

• Receptor‑pathway hierarchy and signaling dominance

• Multi‑axis energy‑regulation models

• Synergistic vs. independent receptor activation

📡 Mechanistic Research Overview

🔵 GLP‑1R‑Linked Signaling

• Referenced in studies examining incretin‑associated transcriptional activity

• Used in models exploring metabolic‑stress signaling pathways

• Supports investigation of receptor‑linked intracellular signaling cascades

🟠 GIPR‑Linked Signaling

• Applied in research involving adipocyte‑associated signaling markers

• Supports studies of incretin‑mediated receptor cross‑talk

• Used in comparative incretin‑pathway modeling

🟣 GCGR‑Linked Signaling

• Examined in glucagon‑associated energy‑mobilization research

• Supports hepatic‑signaling pathway modeling

• Used in receptor‑specific activation studies

🔗 Triple‑Agonist Integration

• Enables analysis of balanced vs. biased receptor activation

• Supports multi‑axis metabolic‑signaling models

• Used in studies exploring synergistic pathway behavior

🧱 Molecular & Chemical Characteristics

Type: Synthetic long‑chain triple‑agonist peptide
Form: Lyophilized powder
Available Fill Sizes: 10 mg / 20 mg / 30 mg
Identity Verification: Mass Spectrometry (MS)
Purity Analysis: HPLC / UPLC

Structural & Biochemical Notes

• Sequence includes stabilizing modifications for protease resistance

• Incorporates a fatty‑acid conjugation region to support albumin association in vitro

• Demonstrates predictable behavior in receptor‑binding and analytical workflows

• Sensitive to hydrolysis and oxidation post‑reconstitution

🔬 Research Focus Areas

Retatrutide is commonly referenced in laboratory research involving:

• Triple‑agonist incretin‑pathway modeling

• GLP‑1R / GIPR / GCGR receptor cross‑talk analysis

• Metabolic‑stress and energy‑balance studies

• Receptor‑specific vs. receptor‑balanced signaling comparisons

• Long‑chain peptide stability and degradation‑resistance assays

• Structure–function analysis of multi‑agonist peptide analogs

Its broad mechanistic scope supports advanced, pathway‑specific metabolic‑biology research in regulated laboratory settings.

❄️ Storage & Handling Guidelines

• Store lyophilized peptide at –20 °C, protected from light and moisture

• Reconstituted solutions: 2–8 °C, short‑term research use only

• Avoid prolonged exposure to room temperature after reconstitution

• Avoid repeated freeze–thaw cycles; aliquot when necessary

• Use sterile preparation techniques and low‑binding labware

📄 Certificate of Analysis & Documentation

Each batch of Retatrutide supplied by BlueNexLabs includes audit‑ready documentation, ensuring traceability and reproducibility:

• Mass Spectrometry identity confirmation

• HPLC / UPLC purity profile

• Solvent system disclosure

• Lot and batch traceability

• Research‑Use‑Only (RUO) designation

🔗View Certificate of Analysis (COA)
🔗Learn About Our Testing Standards
🔗 Explore the BlueNexLabs Research Peptide Catalog

🇨🇦 Supplied for Canadian Research Laboratories

BlueNexLabs supplies Retatrutide research peptide to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and throughout Canada.

Why Researchers Choose BlueNexLabs

• 🇨🇦 Canada‑wide domestic shipping

• 📄 COA‑verified, traceable batches

• 🧪 Audit‑safe RUO labeling

• ⚡ Fast fulfillment & responsive support

• 🔬 Research‑focused metabolic‑pathway peptide catalog

⚠️ Compliance Notice

This product is supplied strictly for laboratory research use only (RUO).
Not for human or veterinary use.
No medical, therapeutic, metabolic, diagnostic, or performance‑related claims are made or implied.